Management of Complicated Skin and Soft‑Tissue Infections (SSTIs)

Assessment of Severity and Necrotizing Potential

The IDSA advises that systemic toxicity (temperature > 38.5 °C, heart rate > 110 bpm, hypotension, altered mental status) signals a severe infection requiring urgent evaluation. 1, 2
Erythema extending > 5 cm from the wound margin is a key metric for escalating care. 1, 2
Presence of bullae, skin sloughing, crepitus, or necrosis indicates possible necrotizing fasciitis and mandates immediate surgical consideration. 1, 2
Pain that is disproportionate to visible findings is a hallmark of necrotizing infection. 1
Laboratory evidence of a white‑blood‑cell count > 12,000 cells/µL or < 4,000 cells/µL supports a diagnosis of severe SSTI. 1

When any necrotizing sign or systemic toxicity is identified, the IDSA recommends obtaining an urgent surgical consult for possible debridement. 1, 2
Rapid progression of erythema, severe disproportionate pain, skin necrosis or bullae, systemic toxicity, or crepitus are red‑flag findings that also trigger immediate surgical involvement. 1, 2

For suspected necrotizing infection, start broad‑spectrum coverage immediately: vancomycin or linezolid plus piperacillin‑tazobactam or a carbapenem. 1, 2
If erythema > 5 cm or systemic signs are present, add MRSA‑active agents (vancomycin, daptomycin, or linezolid) to levofloxacin, because levofloxacin alone may lack adequate gram‑positive activity. 3
Levofloxacin monotherapy has reduced activity against MRSA compared with vancomycin or linezolid. 3
For complicated infections with ascending erythema, the IDSA recommends combination therapy or broader antimicrobial coverage. 1, 3

The IDSA emphasizes that I&D is the most important therapeutic step for wound infections; it may be more critical than antibiotics. 1, 2
When erythema < 5 cm and systemic signs are minimal, I&D alone may suffice without additional antibiotics. 1, 2
Obtain wound cultures (aerobic and anaerobic) before or at the time of I&D to guide definitive antimicrobial therapy. 1, 3

Surgical drainage—opening the wound, evacuating infected material, and performing regular dressing changes—is paramount. 1, 2
Elevation and immobilization of the affected limb reduce swelling and improve outcomes. 1
Obtain aerobic and anaerobic wound cultures to enable targeted de‑escalation of antibiotics. 1, 2, 3

Vancomycin 15–20 mg/kg IV every 8–12 h, linezolid 600 mg IV/PO twice daily, or daptomycin 4 mg/kg IV daily, per IDSA guidance. 3

Total antibiotic course of 7–14 days, adjusted according to clinical response, is recommended for complicated SSTIs. 3

The cited recommendations are derived from IDSA clinical practice guidelines; specific grades of recommendation or levels of evidence are not detailed in the source material.

All patient identifiers have been generalized to protect privacy.

Presence of purulent material signifies an abscess that requires incision and drainage (IDSA guideline) 4
Early post‑traumatic infections (within 48 h) are most commonly caused by Streptococcus pyogenes or Clostridium species, indicating a need for prompt antimicrobial coverage (IDSA guideline) 4
Erythema extending >5 cm beyond the wound margin escalates the severity classification and mandates more aggressive management (IDSA guideline) 4

Incision and drainage (I&D) should be performed immediately to evacuate the purulent collection (IDSA guideline) 4

According to IDSA criteria, patients who have any of the following—temperature > 38.5 °C, heart rate > 110 bpm, or erythema > 5 cm—require systemic antibiotics in addition to I&D 4
Empiric coverage for MRSA is recommended as first‑line therapy (e.g., vancomycin, linezolid, or daptomycin) (IDSA guideline) 4
If erythema exceeds 5 cm or systemic signs worsen, add gram‑negative coverage (e.g., piperacillin‑tazobactam or a carbapenem) (IDSA guideline) 4
Total antibiotic course should be 7–14 days, adjusted according to clinical response (IDSA guideline) 4
When post‑I&D assessment shows erythema < 5 cm and rapid resolution of systemic signs, antibiotics may be omitted and drainage alone may suffice (IDSA guideline) 4

Open the wound and perform regular dressing changes until healing by secondary intention is achieved (IDSA guideline) 4
If no clinical improvement is observed within 24–48 hours after I&D and antibiotics, reassess for deeper infection or resistant organisms and modify antimicrobial therapy accordingly (IDSA guideline) 4